Navigation Links
DePuy Knee Sleeve Failure Allegation Claims Now Being Investigated by Resource4thePeople Attorneys
Date:5/31/2013

San Diego, CA (PRWEB) May 31, 2013

http://www.resource4thepeople.com/defectivemedicaldevices/depuy-knee-sleeve-lawsuits.html

Resource4thePeople announced today that its national team of attorneys is now investigating claims from consumers who are alleging that they suffered serious health problems from DePuy knee sleeves.

"In response to numerous consumer inquiries about whether claims are also being investigated by our national network of lawyers we are now informing consumers that free consultations about such claims are available," said Resource4thePeople.

"This avenue of legal information is being added to our previous offer of free consultations involving consumer inquiries about lawsuits involving such allegations about DePuy knee sleeve lawsuits."

These announcements come in response to a "huge consumer reaction" to a Class 1 Recall issued by the U.S. Food and Drug Administration of the DePuy Orthopaedics LPS Diaphyseal Knee Sleeve in which authorities warned* that the failure of the device could have life-threatening consequences.

FDA officials, in their “Reason for Recall” explaining the action included a warning that health complications as drastic as death could occur if this device malfunctions, said Resource4thePeople.

“The LPS Diaphyseal Sleeve to Diaphyseal Sleeve Base taper connection may not be sufficient to accommodate potential physiologic loads that may be transferred to the junction during normal gait activities by some patients,” the FDA said in its warning.

“This may result in fracture of the sleeve at the taper joint which may also lead to loss of function or loss of limb, infection, compromised soft tissue or death.”

The FDA issued the warning on Feb. 22, 2013.

“The increase in the inquiries we have been receiving from consumers who may have been affected by this recall centers on questions about what legal compensation they may be eligible to receive," said Resource4thePeople.

“This is the most serious type of recall by FDA regulators and we are encouraging patients who may have suffered these dangerous side effects to fully inform themselves about what legal rights they may have to seek compensation in this situation.”

The consultations may provide consumers with information about the legal options they may be entitled to in seeking compensation for medical costs, pain and suffering, loss of wages and other costs that may have been incurred.

The DePuy Orthopaedics LPS Diaphyseal Knee Sleeve is described by the manufacturer as an end-stage revision knee device that has been used in numerous operations by surgeons who are reconstructing severe soft tissue and bony defects. The diaphyseal sleeve is intended to enhance the fit and fill of the diaphyseal femoral canal with femoral and tibial replacements.

The FDA issued the Class 1 Recall of the DePuy Orthopaedics LPS Diaphyseal Knee Sleeve in an urgent notification to health care professionals and consumers.

The FDA in the announcement describes Class I Recalls as the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.

The FDA said in its announcement that the LPS Diaphyseal Sleeve to Diaphyseal Sleeve Base taper connection may not be sufficient to accommodate potential physiologic loads that may be transferred to the junction during normal gait activities by some patients.

The FDA said it acted after receiving 10 reports (6 fractures and 4 reports of loosening that may or may not be attributed to the same device design issue) of incidents in which the device has malfunctioned.

DePuy has informed the FDA that the affected devices were manufactured from 2008 to July 20, 2012 and that it has recommended that hospitals and surgeons immediately stop distributing or using the recalled lots.

Resource4thePeople attorneys are investigating the following side effects that DePuy has identified as adverse events in connection with the use of the DePuy knee sleeve with the DePuy Limb Preservation System:**

"Some of the most common adverse events associated with the device include a change in the position of the components, loosening, bending, cracking, fracture, deformation or wear of components, fatigue fractions, infection, tissue reaction to wear debris, pain, dislocation, decreased range of motion and loss of limb."

“Patients and health care professionals place their trust in the integrity of medical devices but on some occasions these devices can malfunction,” said Resource4thePeople.

“In such cases consumers or loved ones who may have been injured as a result of a failed or recalled device should know that there are legal options available to them to seek compensation and we will actively update them about their legal rights and future developments affecting this product.”

Resource4thePeople also notes that the DePuy knee sleeves are not the first medical products manufactured by DePuy Orthopaedics that have been the subject of massive recalls and numerous lawsuits on behalf of patients injured by those products.

DePuy recalled*** thousands of its metal-on-metal hip implant systems in 2010 and thousands of DePuy metal-on-metal hip implant lawsuits have been filed by patients alleging injuries in a federal court system multi-district litigation.****

Bloomberg News, in a Jan. 18, 2013 analysis***** of the litigation, said that DePuy’s parent company, Johnson & Johnson is defending itself against more than 10,000 lawsuits over the recalled hip implants and may face over $2 billion in legal costs.

“In 2010, J&J recalled 93,000 all-metal hips worldwide, including 37,000 in the U.S., saying more than 12 percent failed within five years,” said Bloomberg. “Patients who sued contend they suffer pain and are immobilized by joint dislocations, infections and bone fractures. They alleged metal debris from the hips causes tissue death around the joints.”

Sources:
*http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm340708.htm Feb. 22, 2013
**http://www.gsortho.org/files/dpy_lps_limb_preservation_sys_surgtech_0612-36-500r3.pdf
*** http://www.depuy.com/asr-hip-replacement-recall
**** DePuy Orthopaedics Multidistrict Litigation # MDL 2197 U.S. District Court, Northern District of Ohio
***** http://www.bloomberg.com/news/2013-01-18/j-j-said-to-offer-implant-pact-that-may-reach-2-billion.html

Read the full story at http://www.prweb.com/releases/2013/5/prweb10777764.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
2. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
3. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
4. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Know The Symptoms Of A Failure And Offers To Name The Best Lawyers & Law Firms For Failure Victims
5. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
6. US Drug Watchdog Dramatically Increases Their Efforts To Get All Recalled DePuy ASR Hip Implant Recipients Identified To The Best Possible Attorneys Before Time Runs Out
7. US Drug Watchdog Now Offers To Help All Recalled DePuy ASR Hip Implant Recipients Get To The Best Attorneys Out Of Fear These Recipients Won't Be Compensated
8. The US Drug Watchdog Now Offers To Help All Recipients Of Recalled DePuy ASR Hip Implant Get To The Best Attorneys Because Time Could Run Out To Get Them Identified
9. US Drug Watchdog Says Its Critical All DePuy Pinnacle Hip Implant Recipients Know The Symptoms Of A Failure And They Offer The Names Of The Best Attorneys For Victims
10. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Get A Blood Test For Elevated Levels Of Cobalt Or Chromium and to Call Them If The Levels Are high
11. US Drug Watchdog Now Urges All DePuy Pinnacle And DePuy Hip Implant Recipients To Call Them For The Names Of The Best Law Firms Before Time Runs Out To Get Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 2016 , ... PharmMD CEO Robert Yeager announced ... on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include ... data breaches for the Part D Star Rating improvement and Medication Therapy Management ...
(Date:2/11/2016)... Island, NY (PRWEB) , ... February 11, 2016 ... ... has enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, to ... leader in vein illumination with an estimated 85% share of the market, facilitates ...
(Date:2/11/2016)... ... , ... The annual list showcases the 20 Most Promising SharePoint Solution Providers ... and commitment to the SharePoint ecosystem. A panel of experts and members of CIOReview’s ... recognize and promote technology entrepreneurship. , The survey was made at the end ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... ergoFET force gauges used in physical therapy, occupational therapy and sports medicine clinics, ... resistance cord exercise and therapy, introduces its new microFET Digital Pinch Gauge. ...
(Date:2/11/2016)... ... February 11, 2016 , ... Research led by Providence Health ... common cancer screenings, especially among women. Cancer screenings are often the best way ... The study,“What Does Medicaid Expansion Mean for Cancer Screening and Prevention: Results from ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 North America , ... MarketsandMarkets, The global market is expected to reach USD 20,190.1 Million ... CAGR of 10.2%. --> North America , ... by MarketsandMarkets, The global market is expected to reach USD 20,190.1 ... a CAGR of 10.2%. --> According to a new ...
(Date:2/10/2016)... SINGAPORE , Feb. 11, 2016  QT Vascular ... "QT Vascular", and together with its subsidiaries, the ... its ongoing litigation with AngioScore, Inc. ("ÄngioScore") (now ... the United States ... (the "Federal Circuit") reversed an earlier district court ...
(Date:2/10/2016)... PITTSBURGH , 10 februari ... och detta pressmeddelande får inte distribueras, vare ... och inga anmälningssedlar kommer att accepteras från ... land där Erbjudandet, distribution av detta pressmeddelande ... strida mot tillämpliga lagar eller regler eller ...
Breaking Medicine Technology: